News & Resources

Virtual Discussion Boards Offer Flexible Solutions for Outreach and Engagement

For some industries, in-person events may not return for quite some time. In the medical and science fields, the shift from live to digital may be permanent. After all, virtual meetings have many advantages. Digital tools let attendees discuss topics, share resources, and network. There’s no need for expensive travel, and busy providers don’t have to close their practice. Virtual meetings and conferences let participants join in from anywhere in the world. They save time and money, and ensure a diverse group of attendees.

Virtual meetings are here to stay, so it’s time for companies to take a close look at their long-term strategies. Digital tools are a great asset, but your company may not be using them to their fullest potential. With careful planning, your organization can make the most of virtual communications. Online discussion boards are a great place to start; these tools allow for fast and efficient collaborations. Read on to learn more.

Virtual discussion boards are flexible
While synchronous meetings allow for focused discussion, they aren’t always convenient. Participants can’t always join in the conversation at a preset time. If attendees can’t make it to the meeting, they may miss out. These meetings also have disadvantages for participants; during a limited time period, it can be difficult for everyone to make their voices heard.

Virtual tools allow for asynchronous discussion – participants can log in anytime, from the location of their choice. Since discussion boards are available 24/7, scheduling conflicts disappear. Participants in many countries and time zones can join in. Providers don’t have to close their office or clear their workday schedule; instead, they can participate during evenings and weekends. Discussion boards help your organization stay connected, even during quarantines or event cancellations.

Discussion boards provide access to experts
Companies need input from a wide range of experts and thought leaders. KOLs can help your company throughout the product and brand planning process. They offer targeted insights and feedback that streamline your operations. If you’re heading in the wrong direction, KOL feedback can help you course-correct. Without insight from experts, companies can face expensive pitfalls.

What should I look for in a discussion platform?
Anonymity
Groupthink can flourish in discussion forums; if anonymity isn’t an option, participants may hesitate to offer candid feedback. To ensure that your company receives unbiased responses, prioritize anonymity. Look for platforms that allow many communication channels, including anonymous comments.

Flexible discussion tools
Some virtual platforms have limited uses. They may restrict the number of threads, topics, or forums. In a restricted setting, it can be difficult to encourage free-form discussion, but flexible tools help participants engage in natural conversations. The right platform lets users chat and network as if they were at a convention.

Small group discussion
KOL outreach thrives during individual discussions and breakout sessions. Choose a platform that supports these functions. Small group discussion lets your team develop a deeper relationship with KOLs. Breakout sessions allow participants to introduce new topics and keep the discussion flowing.

Multimedia functions
For rich, engaging discussions, your team needs access to multimedia tools. Attendees also need a way to collect information in a centralized location. During a conversation, participants will want to share research material. If they switch between platforms to send files, valuable information can be lost. Choose discussion platforms that allow for fast, simple information-sharing. If possible, look for a platform that offers insight reports or ARS. These tools help you quickly collate and analyze feedback.

Tech support
Digital tools don’t always work as planned. During the spring and summer, many companies found this out the hard way. Shifting from in-person discussions to virtual meetings can be a tough transition. A robust tech support team, however, helps smooth away difficulties. Seek out platforms that offer integrated tech support. Make sure your contacts and discussion participants also have access to troubleshooting resources.

The bottom line
KOL outreach is an essential part of your business strategy. In-person meetings aren’t always feasible, but virtual tools can help bridge the gap. Discussion boards offer a way to connect with KOLs 24/7. With the right platform, your team can network and gather valuable insight. These tools help keep your strategic planning on track.

Aptitude Health’s ONCOBOARD
Aptitude Health’s ONCOBOARD lets you communicate with a curated team of experts. Your company can access a closed discussion board with oncology and hematology experts. The platform allows in-depth conversations on a variety of topics. ONCOBOARD also offers insight reports that capture and analyze feedback. Platforms like ONCOBOARD help your company quickly reach out to experts and they collect feedback in one centralized location.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.